MetaADEDB 2.0 @ LMMD
desloratadine
(JAUOIFJMECXRGI-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1
Type(s)
Approved; Investigational
ATC code(s)
R06AX27
Molecular Formula:
C19H19ClN2
Molecular Weight:
310.821
Log P:
4.3477
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
24.92
CAS Number(s):
100643-71-8
Synonym(s)
1.
desloratadine
2.
Aerius
3.
Clarinex
4.
Neoclarityn
5.
SCH 34117
6.
SCH-34117
7.
descarboethoxyloratadine
8.
descarboethoxyloratadine acetate
External Link(s)
MeSHC121345
PubChem Compound124087
BindingDB50073179
ChEBI291342
CHEMBLCHEMBL1172
DrugBankDB00967
DrugCentral814
IUPHAR/BPS Guide to PHARMACOLOGY7157
KEGGdr:D03693
Therapeutic Target DatabaseD01GBY
ZINC1261
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 48
Canada Vigilance: 50
Canada Vigilance
US FAERS
2DizzinessFAERS: 36
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3FatigueFAERS: 30
Canada Vigilance: 5
17288686CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
4HeadacheFAERS: 28
Canada Vigilance: 8
17288686CTD
SIDER
Canada Vigilance
US FAERS
5HypersensitivityFAERS: 25
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
6SomnolenceFAERS: 25
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
7VomitingFAERS: 25
Canada Vigilance: 2
17288686CTD
SIDER
Canada Vigilance
US FAERS
8Drug dose omissionFAERS: 20US FAERS
9No adverse eventFAERS: 20US FAERS
10TachycardiaFAERS: 20
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11NauseaFAERS: 19
Canada Vigilance: 3
17288686CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
12PalpitationsFAERS: 19
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
13UrticariaFAERS: 17
Canada Vigilance: 3
11277962CTD
SIDER
Canada Vigilance
US FAERS
14AgitationFAERS: 16
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
15AngioedemaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16OverdoseFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
17MalaiseFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
18MyalgiaFAERS: 14SIDER
US FAERS
19AstheniaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
20Abdominal PainFAERS: 12SIDER
US FAERS
21AsthmaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
22Cytolytic hepatitisFAERS: 12OFFSIDES
US FAERS
23Feeling abnormalFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
24Anaphylactic shockFAERS: 11SIDER
US FAERS
25Product substitution issueFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
26DeliriumFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
27EpistaxisFAERS: 8
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
28ErythemaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
29Product use in unapproved indicationFAERS: 8US FAERS
30AnxietyFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
31ArthralgiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
32CholestasisFAERS: 715962395CTD
US FAERS
33EpilepsyFAERS: 7US FAERS
34Product availability issueFAERS: 7US FAERS
35Product supply issueFAERS: 7US FAERS
36Product use issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
37TinnitusFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
38Chest discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
39ChillsFAERS: 6US FAERS
40Depressed moodFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Drug exposure during pregnancyFAERS: 6US FAERS
42DysgeusiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
43HepatitisFAERS: 6SIDER
US FAERS
44NervousnessFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
45RestlessnessFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
46TremorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
47VertigoFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Abdominal discomfortFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Chest PainFAERS: 5
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
50DiplopiaFAERS: 5US FAERS
51HypotensionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
52MydriasisFAERS: 5US FAERS
53Myocardial InfarctionFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
54Product quality issueFAERS: 5US FAERS
55PruritusFAERS: 5
Canada Vigilance: 3
11277962CTD
SIDER
Canada Vigilance
US FAERS
56WheezingFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
57Accidental overdoseFAERS: 4US FAERS
58AgeusiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
59AsphyxiaFAERS: 4US FAERS
60BronchospasmFAERS: 4US FAERS
61Burning sensationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
62DisorientationFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
63Head discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Inappropriate schedule of drug administrationFAERS: 4US FAERS
65Intentional misuseFAERS: 4US FAERS
66LethargyFAERS: 4US FAERS
67Lip swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Medication ErrorFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
69PainFAERS: 4
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
70RhinitisFAERS: 415962395CTD
US FAERS
71Suicide attemptFAERS: 4US FAERS
72Supraventricular tachycardiaFAERS: 4US FAERS
73SyncopeFAERS: 4US FAERS
74Toxicity to various agentsFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Urinary RetentionFAERS: 4US FAERS
76VasculitisFAERS: 4US FAERS
77Adverse eventFAERS: 3US FAERS
78Atrial FibrillationFAERS: 3US FAERS
79Back PainFAERS: 3US FAERS
80Breast CystFAERS: 3US FAERS
81Cerebrovascular accidentFAERS: 3US FAERS
82DehydrationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Depressed Level of ConsciousnessFAERS: 3US FAERS
84Diabetes MellitusFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
85Drug ToleranceFAERS: 3US FAERS
86Drug dispensing errorFAERS: 3US FAERS
87Drug prescribing errorFAERS: 3US FAERS
88DyspepsiaFAERS: 3OFFSIDES
SIDER
US FAERS
89DysphoniaFAERS: 3OFFSIDES
US FAERS
90Ear discomfortFAERS: 3US FAERS
91Educational problemFAERS: 3US FAERS
92Erythema MultiformeFAERS: 3OFFSIDES
US FAERS
93Feeling jitteryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Gastrointestinal carcinomaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Gluten sensitivityFAERS: 3US FAERS
96KetoacidosisFAERS: 3US FAERS
97LymphadenopathyFAERS: 3US FAERS
98Memory impairmentFAERS: 3US FAERS
99Nasal discomfortFAERS: 3US FAERS
100Nephrotic SyndromeFAERS: 3US FAERS
101Oropharyngeal painFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
102PneumoniaFAERS: 3US FAERS
103Prescribed overdoseFAERS: 3US FAERS
104Product taste abnormalFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
105Reaction to drug excipientsFAERS: 3US FAERS
106Respiratory tract congestionFAERS: 3US FAERS
107Sense of oppressionFAERS: 3US FAERS
108ShockFAERS: 3US FAERS
109Skin test positiveFAERS: 3US FAERS
110Throat irritationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Unevaluable eventFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Unexpected therapeutic drug effectFAERS: 3US FAERS
113Unresponsive to stimuliFAERS: 3US FAERS
114Weight decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
115AbasiaFAERS: 2US FAERS
116Alcohol interactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Allergy to arthropod biteFAERS: 2US FAERS
118AlopeciaFAERS: 2US FAERS
119AnosmiaFAERS: 2US FAERS
120Blood cholesterol increasedFAERS: 2US FAERS
121BronchitisFAERS: 2OFFSIDES
SIDER
US FAERS
122Cold sweatFAERS: 2OFFSIDES
US FAERS
123ConstipationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Drug DependenceFAERS: 2US FAERS
125Drug administration errorFAERS: 2US FAERS
126Drug screen positiveFAERS: 2US FAERS
127Dry skinFAERS: 2OFFSIDES
US FAERS
128DysphemiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
129DystoniaFAERS: 2US FAERS
130Emotional disorderFAERS: 2US FAERS
131Erectile dysfunctionFAERS: 2US FAERS
132Expired drug administeredFAERS: 2OFFSIDES
US FAERS
133Expired product administeredFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
134General physical condition abnormalFAERS: 2US FAERS
135General physical health deteriorationFAERS: 2OFFSIDES
US FAERS
136GlaucomaFAERS: 2US FAERS
137Hallucinations, mixedFAERS: 2US FAERS
138HemiparesisFAERS: 2US FAERS
139HypersomniaFAERS: 2US FAERS
140HyporeflexiaFAERS: 2US FAERS
141Impaired work abilityFAERS: 2US FAERS
142Inappropriate schedule of product administrationFAERS: 2US FAERS
143Incorrect drug administration durationFAERS: 2US FAERS
144InflammationFAERS: 2US FAERS
145Intentional self-injuryFAERS: 2US FAERS
146Multiple allergiesFAERS: 2US FAERS
147Musculoskeletal stiffnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
148NephrolithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Nonspecific reactionFAERS: 2US FAERS
150Oropharyngeal swellingFAERS: 2US FAERS
151PallorFAERS: 2US FAERS
152PetechiaeFAERS: 2US FAERS
153PregnancyFAERS: 2US FAERS
154Product solubility abnormalFAERS: 2US FAERS
155PurpuraFAERS: 2US FAERS
156Respiratory distressFAERS: 2US FAERS
157Secretion dischargeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Skin lesionFAERS: 2US FAERS
159StressFAERS: 2OFFSIDES
US FAERS
160SwellingFAERS: 2US FAERS
161ThrombocytopeniaFAERS: 2US FAERS
162TorticollisFAERS: 2US FAERS
163Transaminases increasedFAERS: 2US FAERS
164Traumatic Brain InjuryFAERS: 2US FAERS
165Urethral StenosisFAERS: 2US FAERS
166Urine flow decreasedFAERS: 2US FAERS
167Wrong technique in product usage processFAERS: 2US FAERS
168Abnormal sleep-related eventFAERS: 1US FAERS
169Accidental drug intake by childFAERS: 1US FAERS
170Accidental exposure to product by childFAERS: 1US FAERS
171Acoustic stimulation tests abnormalFAERS: 1US FAERS
172Activities of daily living impairedFAERS: 1US FAERS
173Adenoidal disorderFAERS: 1US FAERS
174Alanine Aminotransferase IncreasedFAERS: 1US FAERS
175Alcohol poisoningFAERS: 1US FAERS
176Altered state of consciousnessFAERS: 1US FAERS
177AmnesiaFAERS: 1OFFSIDES
US FAERS
178AneurysmFAERS: 1US FAERS
179AngerFAERS: 1OFFSIDES
US FAERS
180Angina PectorisFAERS: 1US FAERS
181Ankylosing spondylitisFAERS: 1US FAERS
182AnorexiaFAERS: 1SIDER
US FAERS
183Anti-thyroid antibody positiveFAERS: 1US FAERS
184Antithrombin III decreasedFAERS: 1US FAERS
185AnuriaFAERS: 1US FAERS
186AphoniaFAERS: 1US FAERS
187AppendicitisFAERS: 1OFFSIDES
US FAERS
188Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
189AtaxiaFAERS: 119356011CTD
US FAERS
190AtelectasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Atrial FlutterFAERS: 1US FAERS
192Autoimmune hepatitisFAERS: 1US FAERS
193BedriddenFAERS: 1US FAERS
194Bilirubin conjugated increasedFAERS: 1US FAERS
195BlindnessFAERS: 1US FAERS
196Blood albumin abnormalFAERS: 1US FAERS
197Blood glucose increasedFAERS: 1US FAERS
198Blood prolactin increasedFAERS: 1US FAERS
199BradycardiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
200Breast FeedingFAERS: 1US FAERS
201Bronchial ObstructionFAERS: 1US FAERS
202Cardiac ArrestFAERS: 1US FAERS
203CardiotoxicityFAERS: 1US FAERS
204Cerebral InfarctionFAERS: 1US FAERS
205CheilitisFAERS: 1US FAERS
206Choking sensationFAERS: 1OFFSIDES
US FAERS
207ChokingFAERS: 1US FAERS
208ChromaturiaFAERS: 1US FAERS
209Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
210ColitisFAERS: 1US FAERS
211ConjunctivitisFAERS: 1US FAERS
212Convulsion in childhoodFAERS: 1US FAERS
213Coronary Artery DiseaseFAERS: 1US FAERS
214CryingFAERS: 1US FAERS
215DementiaFAERS: 1US FAERS
216DermatitisFAERS: 1SIDER
US FAERS
217Diabetic KetoacidosisFAERS: 1US FAERS
218DiscomfortFAERS: 1US FAERS
219Disease recurrenceFAERS: 1US FAERS
220Documented hypersensitivity to administered drugFAERS: 1US FAERS
221Drug administered to patient of inappropriate ageFAERS: 1US FAERS
222Drug effect incompleteFAERS: 1US FAERS
223Drug level increasedFAERS: 1US FAERS
224Drug toxicityFAERS: 1US FAERS
225DysuriaFAERS: 1US FAERS
226EczemaFAERS: 1OFFSIDES
US FAERS
227Electrocardiogram PQ interval prolongedFAERS: 1US FAERS
228EncephalitisFAERS: 1US FAERS
229EnuresisFAERS: 1US FAERS
230EpiglottitisFAERS: 1US FAERS
231EructationFAERS: 1US FAERS
232Euphoric moodFAERS: 1US FAERS
233Extra dose administeredFAERS: 1US FAERS
234Eye RednessFAERS: 1US FAERS
235Facial PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
236FlatulenceFAERS: 1US FAERS
237Foreign body traumaFAERS: 1US FAERS
238FractureFAERS: 1US FAERS
239Gastric BypassFAERS: 1US FAERS
240Gastric LavageFAERS: 1US FAERS
241GastroenteritisFAERS: 1US FAERS
242Gastrointestinal PainFAERS: 1SIDER
US FAERS
243Glucose-6-phosphate dehydrogenase abnormalFAERS: 1US FAERS
244Grip strength decreasedFAERS: 1US FAERS
245Hepatitis B antibody positiveFAERS: 1US FAERS
246Hepatitis BFAERS: 1US FAERS
247HepatomegalyFAERS: 1US FAERS
248HepatotoxicityFAERS: 1US FAERS
249Hypertensive crisisFAERS: 1US FAERS
250HypoxiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
251ImmobileFAERS: 1US FAERS
252Impaired driving abilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
253Inability to afford medicationFAERS: 1US FAERS
254Inappropriate PrescribingFAERS: 1US FAERS
255IncoherentFAERS: 1US FAERS
256IncontinenceFAERS: 1US FAERS
257Incorrect dose administeredFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Incorrect route of product administrationFAERS: 1US FAERS
259Infectious MononucleosisFAERS: 1OFFSIDES
US FAERS
260Injury asphyxiationFAERS: 1US FAERS
261Joint injuryFAERS: 1OFFSIDES
US FAERS
262Joint stiffnessFAERS: 1US FAERS
263Laryngeal ObstructionFAERS: 1US FAERS
264LaryngitisFAERS: 1US FAERS
265Leukocytoclastic vasculitisFAERS: 1US FAERS
266LeukopeniaFAERS: 1US FAERS
267Ligament injuryFAERS: 1US FAERS
268Limb discomfortFAERS: 1US FAERS
269Loss of personal independence in daily activitiesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
270LymphomaFAERS: 1OFFSIDES
US FAERS
271MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
272Male sexual dysfunctionFAERS: 1US FAERS
273Manufacturing issueFAERS: 1US FAERS
274MeningitisFAERS: 1US FAERS
275MetrorrhagiaFAERS: 1US FAERS
276Migraine with AuraFAERS: 1US FAERS
277Mood swingsFAERS: 1SIDER
US FAERS
278Multiple SclerosisFAERS: 1US FAERS
279Musculoskeletal PainFAERS: 1US FAERS
280MyoclonusFAERS: 1US FAERS
281NarcolepsyFAERS: 1US FAERS
282NasopharyngitisFAERS: 1SIDER
US FAERS
283Nerve injuryFAERS: 1US FAERS
284Night sweatsFAERS: 1US FAERS
285Ocular HypertensionFAERS: 1US FAERS
286PancreatitisFAERS: 1US FAERS
287Paranasal sinus discomfortFAERS: 1US FAERS
288ParanoiaFAERS: 1US FAERS
289Pharmaceutical product complaintFAERS: 1US FAERS
290Pharyngolaryngeal PainFAERS: 1US FAERS
291PhotodermatosisFAERS: 1US FAERS
292PlasmacytosisFAERS: 1US FAERS
293Pleuritic painFAERS: 1US FAERS
294PoisoningFAERS: 1US FAERS
295Precocious PubertyFAERS: 1US FAERS
296Prescription drug used without a prescriptionFAERS: 1US FAERS
297PresyncopeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Product formulation issueFAERS: 1US FAERS
299Product label issueFAERS: 1US FAERS
300Product name confusionFAERS: 1US FAERS
301Product prescribing issueFAERS: 1US FAERS
302PurulenceFAERS: 1US FAERS
303Respiratory arrestFAERS: 1US FAERS
304RetchingFAERS: 1US FAERS
305ScotomaFAERS: 1US FAERS
306ScreamingFAERS: 1US FAERS
307Similar reaction on previous exposure to drugFAERS: 1US FAERS
308Sinonasal obstructionFAERS: 1US FAERS
309Sinus TachycardiaFAERS: 1US FAERS
310SinusitisFAERS: 1OFFSIDES
US FAERS
311Skin WrinklingFAERS: 1US FAERS
312SluggishnessFAERS: 1US FAERS
313SneezingFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
314Sphincter of Oddi DysfunctionFAERS: 1US FAERS
315StomatitisFAERS: 1US FAERS
316StridorFAERS: 1US FAERS
317TachyarrhythmiaFAERS: 1US FAERS
318TetanyFAERS: 1US FAERS
319Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
320ThirstFAERS: 1US FAERS
321Tongue bitingFAERS: 1US FAERS
322Tongue blisteringFAERS: 1US FAERS
323Tongue discomfortFAERS: 1US FAERS
324TrismusFAERS: 1US FAERS
325TuberculosisFAERS: 1US FAERS
326Upper respiratory tract congestionFAERS: 1US FAERS
327Upper-airway cough syndromeFAERS: 1US FAERS
328Urinary IncontinenceFAERS: 1US FAERS
329Uterine contractions during pregnancyFAERS: 1OFFSIDES
US FAERS
330Visual ImpairmentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
331Vitreous floatersFAERS: 1US FAERS
332White blood cell count decreasedFAERS: 1US FAERS
333Wrong drug administeredFAERS: 1US FAERS
334Wrong technique in drug usage processFAERS: 1US FAERS
335jaundiceFAERS: 1US FAERS
336nervous system disorderFAERS: 1SIDER
US FAERS
337AbuseOFFSIDES
338Acid refluxOFFSIDES
339AcneCanada Vigilance: 1Canada Vigilance
340Acute Coronary SyndromeOFFSIDES
341Acute bronchitisOFFSIDES
342Acute sinusitisOFFSIDES
343AdenomaOFFSIDES
344AlveolitisOFFSIDES
345AnhidrosisOFFSIDES
346Anti-SS-A antibody positiveOFFSIDES
347Antidepressant drug clearance decreasedOFFSIDES
348ApneaOFFSIDES
349Application site pruritusOFFSIDES
350Application site reactionOFFSIDES
351Arthropod biteOFFSIDES
352Atrioventricular BlockCanada Vigilance: 1Canada Vigilance
353AuraOFFSIDES
354Autoimmune thyroiditisOFFSIDES
355Autonomic neuropathySIDER
356Bacterial sepsisOFFSIDES
357Benign Prostatic HyperplasiaOFFSIDES
358BlepharoptosisOFFSIDES
359Blood creatine phosphokinase BB increasedOFFSIDES
360Blood immunoglobulin EOFFSIDES
361Blood sodium increasedOFFSIDES
362Blood sodiumOFFSIDES
363Blood urine presentCanada Vigilance: 1Canada Vigilance
364Blurred visionOFFSIDES
365Brain ConcussionOFFSIDES
366BronchiectasisOFFSIDES
367BronchopneumoniaOFFSIDES
368BruxismOFFSIDES
369BulimiaOFFSIDES
370BursitisOFFSIDES
371CalcinosisOFFSIDES
372CalciphylaxisOFFSIDES
373Candidiasis of vaginaOFFSIDES
374Cardiac FlutterCanada Vigilance: 1Canada Vigilance
375Cardioactive drug level above therapeuticOFFSIDES
376Carotid bruitOFFSIDES
377Cervicobrachial syndromeOFFSIDES
378ChondromalaciaOFFSIDES
379Chronic Obstructive Airway DiseaseOFFSIDES
380Chronic sinusitisOFFSIDES
381Clostridium difficile colitisOFFSIDES
382Colon adenomaOFFSIDES
383Concomitant disease aggravatedCanada Vigilance: 1Canada Vigilance
384Congenital mitochondrial cytopathyOFFSIDES
385Corneal dystrophyOFFSIDES
386CyanosisOFFSIDES
387Delusional disorder, persecutory typeOFFSIDES
388DependenceOFFSIDES
389Dermoid CystOFFSIDES
390DiabetesOFFSIDES
391Diabetes mellitus inadequate controlOFFSIDES
392DiarrheaOFFSIDES
393DiverticulumOFFSIDES
394DrowsinessOFFSIDES
395Drug resistanceCanada Vigilance: 1Canada Vigilance
396Electrocardiogram abnormalSIDER
397EmbolismCanada Vigilance: 1Canada Vigilance
398Emotional distressOFFSIDES
399EncephalomalaciaOFFSIDES
400EpidermolysisOFFSIDES
401ErysipelasOFFSIDES
402Erythema InfectiosumOFFSIDES
403Essential HypertensionOFFSIDES
404Eustachian tube disorderOFFSIDES
405ExcitabilitySIDER
406Eye painCanada Vigilance: 1Canada Vigilance
407Feeling ColdOFFSIDES
408Feeling of body temperature changeCanada Vigilance: 1Canada Vigilance
409Fluid replacementOFFSIDES
410Foaming at mouthOFFSIDES
411FormicationOFFSIDES
412GamblingOFFSIDES
413GammopathyOFFSIDES
414Gingival HypertrophyOFFSIDES
415GlobulinuriaOFFSIDES
416GranulomaOFFSIDES
417Hay feverOFFSIDES
418Heavy exposure to ultraviolet lightCanada Vigilance: 1Canada Vigilance
419HemicephalalgiaOFFSIDES
420HistoplasmosisOFFSIDES
421House dust allergyOFFSIDES
422HyperkinesiaSIDER
423HyperparathyroidismOFFSIDES
424Hypertensive heart diseaseOFFSIDES
425HypomaniaOFFSIDES
426ImmunosuppressionOFFSIDES
427InfectionSIDER
428InfestationSIDER
429Intentional drug misuseOFFSIDES
430Intervertebral Disc DegenerationOFFSIDES
431Leukopenia neonatalOFFSIDES
432Locked-In SyndromeOFFSIDES
433Lumbar radiculopathyOFFSIDES
434Lupus-like syndromeOFFSIDES
435Lymphocytic infiltrationOFFSIDES
436Lysosomal Storage Diseases28551711CTD
437MastocytosisCanada Vigilance: 1Canada Vigilance
438Motion SicknessCanada Vigilance: 1Canada Vigilance
439Muscle WeaknessOFFSIDES
440Musculoskeletal chest painOFFSIDES
441Musculoskeletal discomfortSIDER
442Myasthenia GravisOFFSIDES
443Neck PainCanada Vigilance: 1Canada Vigilance
444NeuromaOFFSIDES
445Ocular icterusOFFSIDES
446Ocular vascular disorderOFFSIDES
447OnychoclasisOFFSIDES
448Oral Cavity FistulaOFFSIDES
449Oral infectionOFFSIDES
450OsteopeniaOFFSIDES
451Otitis MediaSIDER
452Paranasal sinus hypersecretionCanada Vigilance: 1Canada Vigilance
453PeriodontitisOFFSIDES
454Peripheral swellingCanada Vigilance: 2Canada Vigilance
455PeritonitisOFFSIDES
456PharyngitisSIDER
457PhotophobiaCanada Vigilance: 1Canada Vigilance
458PneumoperitoneumOFFSIDES
459PolyneuropathyOFFSIDES
460Poor quality sleepCanada Vigilance: 1Canada Vigilance
461Post procedural painOFFSIDES
462Product complaintCanada Vigilance: 1Canada Vigilance
463Product packaging issueCanada Vigilance: 1Canada Vigilance
464PyelonephritisOFFSIDES
465Quality of life decreasedOFFSIDES
466Rash erythematousCanada Vigilance: 1Canada Vigilance
467Renal abscessOFFSIDES
468Renal cystOFFSIDES
469Renal massOFFSIDES
470Respiratory FailureOFFSIDES
471Retinal Vein OcclusionOFFSIDES
472Retinal vascular thrombosisOFFSIDES
473RhinorrheaOFFSIDES
474SclerodermaOFFSIDES
475Septic ShockOFFSIDES
476Sinoatrial BlockOFFSIDES
477Sinus bradycardiaOFFSIDES
478Sjogren's SyndromeOFFSIDES
479Skeletal injuryOFFSIDES
480Sleep TalkingOFFSIDES
481SpondylolisthesisOFFSIDES
482Synovial CystOFFSIDES
483TendinitisOFFSIDES
484Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
485Therapeutic product ineffectiveCanada Vigilance: 1Canada Vigilance
486Therapy non-responderCanada Vigilance: 3Canada Vigilance
487Tooth InfectionOFFSIDES
488TracheobronchitisOFFSIDES
489Urinary tract infectionSIDER
490Urine arsenic increasedOFFSIDES
491Vaginal burning sensationOFFSIDES
492Visual disturbanceOFFSIDES
493Vitreous DetachmentOFFSIDES
494Weight GainOFFSIDES
495Xerostomia17288686CTD
496muscle injuryOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.